New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
August 13, 2014
07:33 EDTEPZMEpizyme reports Q2 EPS (40c), consensus (50c)
Reports Q2 revenue $9.49M, consensus $7.58M. Expects to end 2014 with more than $170M in cash and cash equivalents, it believes will fund the company until at least mid-2016, prior to including any potential future milestone payments.
News For EPZM From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
February 8, 2016
08:01 EDTEPZMEpizyme says tazemetostat granted orphan drug designation by FDA
Subscribe for More Information
February 7, 2016
14:13 EDTEPZMEpizyme's tazemetostat receives orphan designation for malignant rhabdoid tumors
Subscribe for More Information
February 2, 2016
07:15 EDTEPZMCanaccord to hold a conference
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.
I agree to the theflyonthewall.com disclaimer & terms of use